Evaxion A/S
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About EVAX
Evaxion A/S, formerly known as Evaxion Biotech A/S, is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.
Find out what a historical investment in Evaxion A/S would be worth today using our EVAX stock calculator.
$45.80M
-
0.00%
51.41K
$6.20
$5.76
$5.76
$12.15
$1.20
Ready to start your investing journey with Stake?
Open an accountEVAX FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in EVAX
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in EVAX
on Stake
Buy EVAX from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of EVAX from only US$10 with fractional shares
